(Q39940166)

15 September 2017

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future (English)

1 reference

15 September 2017

1 reference

0 references

4

Björn Wettermark

1 reference

15 September 2017

Brian Godman

1

1 reference

15 September 2017

Thomas Burkhardt

series ordinal

2

1 reference

15 September 2017

Anna Bucsics

series ordinal

3

1 reference

15 September 2017

Peter Wieninger

series ordinal

5

1 reference

15 September 2017

1 October 2009

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

15 September 2017

1 reference

15 September 2017

9

1 reference

15 September 2017

5

1 reference

15 September 2017

475-484

1 reference

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

15 September 2017

1 reference

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

21 January 2018

1 reference

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

21 January 2018

1 reference

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

21 January 2018

1 reference

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs

21 January 2018

1 reference

Variations and increase in use of statins across Europe: data from administrative databases

21 January 2018

1 reference

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences

21 January 2018

1 reference

Correlation of therapeutic effect of obidoxime and dosing time in the acute intoxication by chlorfenvinphos in rats.

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

Switching statins in Norway after new reimbursement policy: a nationwide prescription study

21 January 2018

1 reference

21 January 2018

1 reference

Overprescribing proton pump inhibitors

21 January 2018

1 reference

Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

Enhancing the rational use of new medicines across European health care systems

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.09.43

1 reference

15 September 2017

1 reference